Tokyo, Japan

Fukushi Hirayama

USPTO Granted Patents = 17 


 

Average Co-Inventor Count = 8.0

ph-index = 5

Forward Citations = 52(Granted Patents)


Location History:

  • Ibaraki, JP (1999)
  • Chuo-ku, JP (2009 - 2011)
  • Tsukuba, JP (2001 - 2012)
  • Tokyo, JP (1992 - 2014)

Company Filing History:


Years Active: 1992-2014

Loading Chart...
Loading Chart...
Loading Chart...
17 patents (USPTO):

Title: Innovator Fukushi Hirayama: Pioneering Advancements in Pharmacology

Introduction

Fukushi Hirayama, a renowned inventor based in Tokyo, Japan, has made significant contributions to the field of pharmacology through his innovative inventions. With a remarkable portfolio of 17 patents, Hirayama's work focuses primarily on compounds that provide therapeutic benefits, particularly in treating conditions related to blood platelets and thrombocytopenia.

Latest Patents

Hirayama's latest patents showcase his commitment to advancing medicinal chemistry. One of his notable inventions includes a 2-acylaminothiazole derivative, which demonstrates excellent effects in proliferating human c-mpl-Ba/F3 cells and increasing platelets. This innovative compound holds promise for treating thrombocytopenia, a medical condition characterized by low platelet counts.

In addition, Hirayama has developed quinolone derivatives engineered to enhance platelet aggregation inhibition. These compounds feature various substituents that improve their pharmacological activity, particularly regarding P2Y12 inhibition. The versatility and potential applications of these compounds highlight Hirayama's expertise and innovative spirit.

Career Highlights

Throughout his career, Fukushi Hirayama has worked with leading pharmaceutical companies that have proven instrumental in developing his innovative ideas. Notably, he was associated with Astellas Pharma GmbH and Yamanouchi Pharmaceutical Company Ltd., where he further refined his expertise in drug development and patenting processes.

Collaborations

Hirayama has worked alongside talented professionals in his field, including Yuji Koga and Keizo Sugasawa. These collaborations have not only enriched his inventions but also contributed to the advancement of research in pharmacology, allowing for a more robust discussion of ideas and technologies related to his work.

Conclusion

Fukushi Hirayama's innovative contributions to the pharmaceutical industry are marked by a series of impactful patents that address significant medical challenges. His dedication to developing compounds that improve platelet function and address thrombocytopenia exemplifies the spirit of innovation and serves as an inspiration for future inventors in pharmacology. As healthcare continues to evolve, Hirayama’s inventions promise to play an essential role in shaping future therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…